Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma by Ami V Desai, Stefani Spranger, Thomas F Gajewski, Yuanyuan Zha, Jason J Luke, Peter Pytel, Kyle Hernandez, Samuel L Volchenboum, Susan L Cohn

Get full text

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy by Pedro J Romero, Leisha A Emens, Elizabeth Garrett-Mayer, Valsamo Anagnostou, Jason J Luke, Ann W Silk, Thomas U Marron, Jane Perlmutter, Brianna Hoffner, Connie Szczepanek

Get full text

Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial by Akshita Gupta, Riyue Bao, F Stephen Hodi, Jaclyn Neely, Jason J Luke, Ashish Massey, Santanu Dutta, Janis Taube, George Lee, Katherine Bever, Peter Szabo, David Yao, Rachel Tam, Tim Reilly

Get full text

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study by Michael Smith, Ignacio Garrido-Laguna, Aung Naing, Lance Leopold, Jason J Luke, Kai Ding, Solmaz Sahebjam, Ryan Geschwindt, John D Powderly, John J Nemunaitis, Aaron S Mansfield, Wells A Messersmith, Patricia M LoRusso, Jordan D Berlin

Get full text

Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors by Yan Zhang, Andrés Cervantes, Stephane Champiat, Aurélien Marabelle, Patricia LoRusso, Jason J Luke, Robert Haddad, David J Pinato, Dejan Juric, María de Miguel, Won Seog Kim, Xiaobin Yuan, Peter J Hosein, Anupam M Desai, Yuanxin Rong

Get full text

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors by Dirk Schadendorf, Ignacio Melero, Robert L Ferris, William Sharfman, Satyendra Suryawanshi, Jaclyn Neely, Fabrice Barlesi, Dung T Le, Jason J Luke, Patrick A Ott, Tina Cascone, Nikhil I Khushalani, Abanti Sanyal, Scott Ely, Manish R Sharma, Deanne Lathers, James L Holloway, Rasika Suryawanshi, Neil H Segal

Get full text

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma by Jessica C Hassel, Alexander N Shoushtari, Omid Hamid, Takami Sato, Paul Nathan, Marcus O Butler, Jason J Luke, Richard D Carvajal, Leonel Hernandez-Aya, Douglas B Johnson, Laura Collins, Enrique Espinosa, Joseph J Sacco, Serge Leyvraz, Alexandra Ikeguchi, Matthew Rioth, Chris Holland, Josep M Piulats

Get full text

Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers by Brandon M. Lehrich, Evan R. Delgado, Tyler M. Yasaka, Silvia Liu, Catherine Cao, Yuqing Liu, Mohammad N. Taheri, Xiangnan Guan, Hartmut Koeppen, Sucha Singh, Vik Meadows, Jia-Jun Liu, Anya Singh-Varma, Yekaterina Krutsenko, Minakshi Poddar, T. Kevin Hitchens, Lesley M. Foley, Binyong Liang, Alex Rialdi, Ravi P. Rai, Panari Patel, Madeline Riley, Aaron Bell, Reben Raeman, Tulin Dadali, Jason J. Luke, Ernesto Guccione, Mo R. Ebrahimkhani, Amaia Lujambio, Xin Chen, Martin Maier, Yulei Wang, Wendy Broom, Junyan Tao, Satdarshan P. Monga

Get full text